ウルソデオキシコール酸の世界市場レポート2025年

ウルソデオキシコール酸の市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.8％で14億4,000万米ドルに成長します。予測される成長の原動力となるのは、生活習慣に関連した健康問題の負担増、肝庇護薬への依存の高まり、長期的な肝疾患治療へのニーズの高まり、胆汁酸誘導体に焦点を当てた臨床試験の充実したパイプライン、侵襲性の低い外科的選択肢への関心の高まりなどです。今後数年間の主な市場動向としては、標的ドラッグデリバリー法の発展、UDCAと他の肝臓保護物質との併用、新たな薬剤製剤戦略、胆汁酸アナログの開発、肝臓再生を目的としたRNAベースの治療法の出現などが挙げられます。

肝疾患の有病率の増加は、今後数年間のウルソデオキシコール酸市場の拡大を牽引すると予想されます。肝疾患には、感染症、炎症、脂肪肝、肝硬変、肝がんなど、肝臓の正常な機能を阻害するさまざまな疾患が含まれます。長期にわたる過度の飲酒は肝臓に大きなダメージを与えるため、肝臓関連疾患の増加の主な要因の1つは、アルコール消費量の増加です。ウルソデオキシコール酸は、胆汁の流れを促進し、有毒な胆汁酸のレベルを低下させることで、肝疾患の治療に重要な役割を果たしています。肝障害の進行を遅らせたり、コレステロール胆石の溶解を助けたりすることで、患者の予後を改善し、治療効果を高めます。例えば、2024年4月、英国の政府機関であるOffice for Health Improvement and Disparitiesは、肝疾患による早期死亡者数を男性で6,664人、女性で3,929人と報告しました。このような肝疾患患者の急増が、ウルソデオキシコール酸市場の成長に寄与しています。

ウルソデオキシコール酸（UDCA）市場の主要企業は、肝疾患、特に胆汁うっ滞性肝障害の治療を改善するために、胆汁酸誘導体などの先進的な治療法の開発をますます進めています。胆汁酸誘導体は、肝機能をサポートし、さまざまな肝疾患を管理するために設計された胆汁酸の化学修飾形態です。例えば、2024年11月、カナダに本社を置く製薬会社Nora Pharma Inc.は、原発性胆汁性胆管炎（PBC）を含む胆汁うっ滞性肝疾患の治療を目的としたウルソジオール（ウルソデオキシコール酸）のジェネリック医薬品を発売しました。この薬剤は、肝機能を亢進させ、特に疾患経過の初期に投与することで肝障害の進行を抑制するために使用されます。さらに、胆汁組成を変化させ、毒性のある胆汁酸レベルを低下させることにより、コレステロール胆石の溶解と予防を助ける。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のウルソデオキシコール酸：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のウルソデオキシコール酸市場：成長率分析
• 世界のウルソデオキシコール酸市場の実績：規模と成長, 2019-2024
• 世界のウルソデオキシコール酸市場の予測：規模と成長, 2024-2029, 2034F
• 世界のウルソデオキシコール酸：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界のウルソデオキシコール酸市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 合成ウルソデオキシコール酸
• 抽出ウルソデオキシコール酸
• 世界のウルソデオキシコール酸市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口
• 静脈内
• 皮下
• 世界のウルソデオキシコール酸市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 胆石
• 原発性胆汁性胆管炎
• 原発性硬化性胆管炎
• 非アルコール性脂肪性肝疾患
• その他の肝臓および胆道疾患
• 世界のウルソデオキシコール酸市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• その他の流通チャネル
• 世界のウルソデオキシコール酸市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 研究機関
• その他のエンドユーザー
• 世界のウルソデオキシコール酸市場、合成ウルソデオキシコール酸、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学合成ウルソデオキシコール酸
• 生合成ウルソデオキシコール酸
• 酵素合成ウルソデオキシコール酸
• 世界のウルソデオキシコール酸市場、抽出ウルソデオキシコール酸、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 動物由来のウルソデオキシコール酸
• 胆汁抽出ウルソデオキシコール酸
• 天然由来抽出ウルソデオキシコール酸

第7章 地域別・国別分析

• 世界のウルソデオキシコール酸市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のウルソデオキシコール酸市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ウルソデオキシコール酸市場：競合情勢
• ウルソデオキシコール酸市場：企業プロファイル
  • Mankind Pharma Pvt. Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Healthcare Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Shandong Octagon Chemicals Limited Overview, Products and Services, Strategy and Financial Analysis
  • J.S.C. Grindeks Overview, Products and Services, Strategy and Financial Analysis
  • Arch Pharmalabs Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Ind Swift Laboratories Ltd.
• Symbiotec Pharmalab
• Suzhou Tianlu Bio-pharmaceutical Co. Ltd
• Zeal MediPharma
• Prodotti Chimici e Alimentari S.P.A.
• Mitsubishi Tanabe Pharma Corporation
• ICE Pharma Inc
• Xi'an Tian Guangyuan Biotech Co. Ltd
• Aamorb Pharmaceuticals Inc.
• Axplora Inc
• Octavius Pharma Pvt. Ltd
• Sichuan Elixir Pharmaceutical Co. Ltd
• Signova Pharma Pvt. Ltd.
• Sinoway Industrial Co. Ltd
• Valence Labs Pvt. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ウルソデオキシコール酸市場2029：新たな機会を提供する国
• ウルソデオキシコール酸市場2029：新たな機会を提供するセグメント
• ウルソデオキシコール酸市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Ursodeoxycholic acid (UDCA) is a naturally occurring bile acid produced in small quantities by the human liver. It is utilized as a medication for dissolving specific types of gallstones and for treating various liver and gallbladder conditions. UDCA aids in dissolving cholesterol-based gallstones and enhances bile flow, thereby safeguarding liver cells from damage. It is widely regarded as a safe and effective treatment for managing cholestatic liver diseases.

There are two primary types of ursodeoxycholic acid: synthetic and extracted. Synthetic UDCA is a laboratory-produced form of the natural bile acid, designed to treat liver disorders and dissolve cholesterol gallstones by enhancing bile flow and minimizing liver cell damage. This formulation can be administered orally, via intravenous injection, or subcutaneously. It is mainly prescribed for conditions such as gallstones, primary biliary cholangitis, primary sclerosing cholangitis, and non-alcoholic fatty liver disease. Distribution channels include hospital pharmacies, retail outlets, and online platforms, serving end users such as hospitals, specialized clinics, research centers, and other institutions.

The ursodeoxycholic acid market research report is one of a series of new reports from The Business Research Company that provides ursodeoxycholic acid market statistics, including the ursodeoxycholic acid industry's global market size, regional shares, competitors with the ursodeoxycholic acid market share, detailed ursodeoxycholic acid market segments, market trends and opportunities, and any further data you may need to thrive in the ursodeoxycholic acid market. This ursodeoxycholic acid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ursodeoxycholic acid market size has grown rapidly in recent years. It will grow from $0.86 billion in 2024 to $0.96 billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. The expansion during the historical period can be attributed to factors such as the rising incidence of gallstone disease, increased awareness regarding liver health, higher diagnosis rates of primary biliary cholangitis, a greater shift toward non-invasive liver testing, and the aging global population.

The ursodeoxycholic acid market size is expected to see rapid growth in the next few years. It will grow to $1.44 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The projected growth will be driven by the rising burden of lifestyle-related health issues, growing reliance on hepatoprotective medications, increased need for long-term liver disease treatments, a robust pipeline of clinical trials focused on bile acid derivatives, and growing interest in less invasive surgical options. Key market trends in the coming years include advancements in targeted drug delivery methods, combining UDCA with other liver-protecting substances, new drug formulation strategies, development of bile acid analogs, and the emergence of RNA-based therapies aimed at liver regeneration.

The growing prevalence of liver diseases is anticipated to drive the expansion of the ursodeoxycholic acid market in the coming years. Liver diseases encompass various conditions that hinder the liver's normal function, such as infections, inflammation, fatty liver, cirrhosis, and liver cancer. One of the key contributors to this increase in liver-related conditions is the rising level of alcohol consumption, as prolonged excessive drinking can cause significant liver damage. Ursodeoxycholic acid plays a crucial role in treating liver diseases by enhancing bile flow and decreasing the levels of toxic bile acids, which makes it particularly effective in managing conditions like primary biliary cholangitis. It helps improve patient outcomes by slowing the progression of liver damage and aiding in the dissolution of cholesterol gallstones, thereby boosting the overall effectiveness of treatments. For example, in April 2024, the Office for Health Improvement and Disparities, a UK-based government department, reported 6,664 premature deaths from liver disease among males and 3,929 among females, reflecting a 22.8% increase for males and a 33.1% increase for females compared to previous years. This surge in liver disease cases is contributing to the growth of the ursodeoxycholic acid market.

Leading companies in the ursodeoxycholic acid (UDCA) market are increasingly developing advanced therapies, such as bile acid derivatives, to improve the treatment of liver diseases, particularly cholestatic liver disorders. Bile acid derivatives are chemically modified forms of bile acids designed to support liver function and manage various liver conditions. For instance, in November 2024, Nora Pharma Inc., a pharmaceutical company based in Canada, introduced a generic version of Ursodiol (ursodeoxycholic acid) aimed at treating cholestatic liver diseases, including primary biliary cholangitis (PBC). This medication is used to enhance liver function and decelerate liver damage progression, especially when administered early in the disease course. Additionally, it helps dissolve and prevent cholesterol gallstones by altering bile composition and reducing toxic bile acid levels.

In November 2022, Sunshine Biopharma Inc., a pharmaceutical company based in the United States, acquired Nora Pharma Inc. for an undisclosed sum. Through this acquisition, Sunshine Biopharma intends to diversify its revenue sources, strengthen its presence in the generic and biosimilar drug sectors, and make strides toward becoming a fully integrated pharmaceutical company. Nora Pharma Inc., headquartered in Canada, markets ursodeoxycholic acid under the brand name NRA-Ursodiol.

Major players in the ursodeoxycholic acid market are Mankind Pharma Pvt. Ltd, Abbott Healthcare Pvt. Ltd., Shandong Octagon Chemicals Limited, J.S.C. Grindeks, Arch Pharmalabs, Ind Swift Laboratories Ltd., Symbiotec Pharmalab, Suzhou Tianlu Bio-pharmaceutical Co. Ltd, Zeal MediPharma, Prodotti Chimici e Alimentari S.P.A., Mitsubishi Tanabe Pharma Corporation, ICE Pharma Inc, Xi'an Tian Guangyuan Biotech Co. Ltd, Aamorb Pharmaceuticals Inc., Axplora Inc, Octavius Pharma Pvt. Ltd, Sichuan Elixir Pharmaceutical Co. Ltd, Signova Pharma Pvt. Ltd., Sinoway Industrial Co. Ltd, and Valence Labs Pvt. Ltd.

North America was the largest region in the ursodeoxycholic acid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ursodeoxycholic acid report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ursodeoxycholic acid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ursodeoxycholic acid market consists of sales of ursodiol tablets, ursodeoxycholic acid capsules, suspensions, injectables, and combination drugs. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ursodeoxycholic Acid Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ursodeoxycholic acid market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ursodeoxycholic acid ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ursodeoxycholic acid market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Synthetic Ursodeoxycholic Acid; Extraction Ursodeoxycholic Acid
• 2) By Route Of Administration: Oral; Intravenous; Subcutaneous
• 3) By Application: Gallstones; Primary Biliary Cholangitis; Primary Sclerosing Cholangitis; Non-Alcoholic Fatty Liver Disease; Other Liver And Biliary Diseases
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• 5) By End User: Hospitals; Specialty Clinics; Research Institutions; Other End Users
• Subsegments:
• 1) By Synthetic Ursodeoxycholic Acid: Chemically Synthesized Ursodeoxycholic Acid; Biosynthetic Ursodeoxycholic Acid; Enzymatically Synthesized Ursodeoxycholic Acid
• 2) By Extraction Ursodeoxycholic Acid: Animal-Derived Ursodeoxycholic Acid; Bile Extracted Ursodeoxycholic Acid; Natural Source Extracted Ursodeoxycholic Acid
• Companies Mentioned: Mankind Pharma Pvt. Ltd; Abbott Healthcare Pvt. Ltd.; Shandong Octagon Chemicals Limited; J.S.C. Grindeks; Arch Pharmalabs
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ursodeoxycholic Acid Market Characteristics

3. Ursodeoxycholic Acid Market Trends And Strategies

4. Ursodeoxycholic Acid Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Ursodeoxycholic Acid Growth Analysis And Strategic Analysis Framework

• 5.1. Global Ursodeoxycholic Acid PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Ursodeoxycholic Acid Market Growth Rate Analysis
• 5.4. Global Ursodeoxycholic Acid Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Ursodeoxycholic Acid Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Ursodeoxycholic Acid Total Addressable Market (TAM)

6. Ursodeoxycholic Acid Market Segmentation

• 6.1. Global Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic Ursodeoxycholic Acid
• Extraction Ursodeoxycholic Acid
• 6.2. Global Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Subcutaneous
• 6.3. Global Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gallstones
• Primary Biliary Cholangitis
• Primary Sclerosing Cholangitis
• Non-Alcoholic Fatty Liver Disease
• Other Liver And Biliary Diseases
• 6.4. Global Ursodeoxycholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.5. Global Ursodeoxycholic Acid Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Research Institutions
• Other End Users
• 6.6. Global Ursodeoxycholic Acid Market, Sub-Segmentation Of Synthetic Ursodeoxycholic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemically Synthesized Ursodeoxycholic Acid
• Biosynthetic Ursodeoxycholic Acid
• Enzymatically Synthesized Ursodeoxycholic Acid
• 6.7. Global Ursodeoxycholic Acid Market, Sub-Segmentation Of Extraction Ursodeoxycholic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Animal-Derived Ursodeoxycholic Acid
• Bile Extracted Ursodeoxycholic Acid
• Natural Source Extracted Ursodeoxycholic Acid

7. Ursodeoxycholic Acid Market Regional And Country Analysis

• 7.1. Global Ursodeoxycholic Acid Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Ursodeoxycholic Acid Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ursodeoxycholic Acid Market

• 8.1. Asia-Pacific Ursodeoxycholic Acid Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ursodeoxycholic Acid Market

• 9.1. China Ursodeoxycholic Acid Market Overview
• 9.2. China Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ursodeoxycholic Acid Market

• 10.1. India Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ursodeoxycholic Acid Market

• 11.1. Japan Ursodeoxycholic Acid Market Overview
• 11.2. Japan Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ursodeoxycholic Acid Market

• 12.1. Australia Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ursodeoxycholic Acid Market

• 13.1. Indonesia Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ursodeoxycholic Acid Market

• 14.1. South Korea Ursodeoxycholic Acid Market Overview
• 14.2. South Korea Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ursodeoxycholic Acid Market

• 15.1. Western Europe Ursodeoxycholic Acid Market Overview
• 15.2. Western Europe Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ursodeoxycholic Acid Market

• 16.1. UK Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ursodeoxycholic Acid Market

• 17.1. Germany Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ursodeoxycholic Acid Market

• 18.1. France Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ursodeoxycholic Acid Market

• 19.1. Italy Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ursodeoxycholic Acid Market

• 20.1. Spain Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ursodeoxycholic Acid Market

• 21.1. Eastern Europe Ursodeoxycholic Acid Market Overview
• 21.2. Eastern Europe Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ursodeoxycholic Acid Market

• 22.1. Russia Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ursodeoxycholic Acid Market

• 23.1. North America Ursodeoxycholic Acid Market Overview
• 23.2. North America Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ursodeoxycholic Acid Market

• 24.1. USA Ursodeoxycholic Acid Market Overview
• 24.2. USA Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ursodeoxycholic Acid Market

• 25.1. Canada Ursodeoxycholic Acid Market Overview
• 25.2. Canada Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ursodeoxycholic Acid Market

• 26.1. South America Ursodeoxycholic Acid Market Overview
• 26.2. South America Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ursodeoxycholic Acid Market

• 27.1. Brazil Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ursodeoxycholic Acid Market

• 28.1. Middle East Ursodeoxycholic Acid Market Overview
• 28.2. Middle East Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ursodeoxycholic Acid Market

• 29.1. Africa Ursodeoxycholic Acid Market Overview
• 29.2. Africa Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ursodeoxycholic Acid Market Competitive Landscape And Company Profiles

• 30.1. Ursodeoxycholic Acid Market Competitive Landscape
• 30.2. Ursodeoxycholic Acid Market Company Profiles
  • 30.2.1. Mankind Pharma Pvt. Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Healthcare Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Shandong Octagon Chemicals Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. J.S.C. Grindeks Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Arch Pharmalabs Overview, Products and Services, Strategy and Financial Analysis

31. Ursodeoxycholic Acid Market Other Major And Innovative Companies

• 31.1. Ind Swift Laboratories Ltd.
• 31.2. Symbiotec Pharmalab
• 31.3. Suzhou Tianlu Bio-pharmaceutical Co. Ltd
• 31.4. Zeal MediPharma
• 31.5. Prodotti Chimici e Alimentari S.P.A.
• 31.6. Mitsubishi Tanabe Pharma Corporation
• 31.7. ICE Pharma Inc
• 31.8. Xi'an Tian Guangyuan Biotech Co. Ltd
• 31.9. Aamorb Pharmaceuticals Inc.
• 31.10. Axplora Inc
• 31.11. Octavius Pharma Pvt. Ltd
• 31.12. Sichuan Elixir Pharmaceutical Co. Ltd
• 31.13. Signova Pharma Pvt. Ltd.
• 31.14. Sinoway Industrial Co. Ltd
• 31.15. Valence Labs Pvt. Ltd.

32. Global Ursodeoxycholic Acid Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ursodeoxycholic Acid Market

34. Recent Developments In The Ursodeoxycholic Acid Market

35. Ursodeoxycholic Acid Market High Potential Countries, Segments and Strategies

• 35.1 Ursodeoxycholic Acid Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Ursodeoxycholic Acid Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Ursodeoxycholic Acid Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer